FIELD: chemistry of heterocyclic compounds with neuroleptic activity. SUBSTANCE: product 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl) ethyl)-6-6chloro-1,3-dihydro-2H-indol-2-one hydrochloride monohydrate has improved stability when preparaing compositions with neuroleptic activity. Monohydrate is prepared by reacting anhydrous 5-(2-(4-(1,2-benzisothiazol-3- -yl)1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one with hydrochloric acid having concentration preferably 0.3-3.0 M and more preferebably 0.7 M. EFFECT: higher efficiency. 5 cl, 6 dwg
Authors
Dates
1997-06-10—Published
1993-08-31—Filed